Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The influenza virus hemagglutinin (HA) stem region is a highly conserved domain of the primary surface glycoprotein responsible for viral entry into host cells (Nature, 2018). While the HA head region undergoes frequent antigenic drift, the stem region (primarily composed of the HA2 subunit) remains relatively invariant across diverse influenza A and B strains (Science, 2015). This conservation makes it a critical target for the development of universal influenza vaccines and broadly neutralizing antibodies (bnAbs) (Cell, 2019). Biologically, the stem region mediates the fusion of the viral envelope with the host endosomal membrane through a pH-triggered conformational change (PNAS, 2016). Therapeutic agents targeting this region, such as monoclonal antibodies like MEDI8852 or small molecules like Umifenovir, function by stabilizing the pre-fusion conformation (The Lancet Infectious Diseases, 2020). By sterically hindering the fusion machinery, these drugs prevent the release of the viral genome into the host cytoplasm (Nature Communications, 2019). This mechanism effectively neutralizes the infection across multiple viral subtypes, offering a broader range of protection than traditional vaccines (Journal of Virology, 2018).
The primary mechanism involves binding to the conserved stem region to sterically block the pH-induced conformational change required for membrane fusion, thereby preventing the release of the viral genome into the host cell (Nature Communications, 2019).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza virus hemagglutinin stem region (HA stem) (HA stem).